Protext Mobility Inc

Chart & performance

D1W1MN

P/E

26.32

P/S

—

EPS

0.00

Div yield, %

—

Shrs. gr., 5y

12.52%

Rev. gr., 5y

-30.66%

Revenues

Net income

510k

CFO

-44k

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.

Key people

Roger Baylis-Duffield

Chief Executive Officer, Director · since 2016

David Lewis

Director · since 2016

URL

http://ww1.protextm.co/

IPO date

Aug 21, 2003

Employees

Domiciled in

Incorporated in

Legal address

C/O National Registered Agents, Inc.
160 Greentree Drive
Suite 101
Dover, DE 19904
US

Headquarters

16885 River Birch Circle
Delray Beach, FL 33445
US

Previous name

ProText Mobility, Inc.

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT